Summary:
- This article discusses recent developments in the biotech industry, including the performance of the XBI index, which tracks biotechnology stocks.
- It also covers the recommendation by the Advisory Committee on Immunization Practices (ACIP) to approve a new RSV vaccine for older adults, and Gilead's acquisition of a company working on a potential treatment for a rare genetic disorder.
- These updates are relevant to the field of biotechnology and have potential implications for the development of new medical treatments and therapies.